Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Olive

Showing results (271-280 of 276) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 276 results.
Mabs|December 18, 2014
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodiesMagdalena Winiarska, Kamil Bojarczuk, Beata Pyrzynska, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcomeAnne-Sophie Chretien, Raynier Devillier, Samuel Granjeaud, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 28, 2025
PD-1<sup>+</sup> NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockadeMarco Greppi, Giovanna Tabellini, Ornella Patrizi, et al.
Cancers|January 28, 2021
Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2<sup>+</sup> γδ T Cell Alterations with Lymph Node InvasionStéphane Fattori, Laurent Gorvel, Samuel Granjeaud, et al.
Cancer Research|November 9, 2012
PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancerCécile Badoual, Stéphane Hans, Nathalie Merillon, et al.
Cancer Research Communications|August 18, 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint BlockadeSapna Yadavilli, Jeremy D Waight, Sara Brett, et al.
Pageof 28

Showing results (271-280 of 276) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 276 results.
Mabs|December 18, 2014
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodiesMagdalena Winiarska, Kamil Bojarczuk, Beata Pyrzynska, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcomeAnne-Sophie Chretien, Raynier Devillier, Samuel Granjeaud, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 28, 2025
PD-1<sup>+</sup> NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockadeMarco Greppi, Giovanna Tabellini, Ornella Patrizi, et al.
Cancers|January 28, 2021
Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2<sup>+</sup> γδ T Cell Alterations with Lymph Node InvasionStéphane Fattori, Laurent Gorvel, Samuel Granjeaud, et al.
Cancer Research|November 9, 2012
PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancerCécile Badoual, Stéphane Hans, Nathalie Merillon, et al.
Cancer Research Communications|August 18, 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint BlockadeSapna Yadavilli, Jeremy D Waight, Sara Brett, et al.
Pageof 28